GB201613828D0 - Therapeutic agents for lysosomal storage disorders - Google Patents

Therapeutic agents for lysosomal storage disorders

Info

Publication number
GB201613828D0
GB201613828D0 GBGB1613828.1A GB201613828A GB201613828D0 GB 201613828 D0 GB201613828 D0 GB 201613828D0 GB 201613828 A GB201613828 A GB 201613828A GB 201613828 D0 GB201613828 D0 GB 201613828D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
lysosomal storage
storage disorders
disorders
lysosomal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1613828.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intrabio Ltd
Original Assignee
Intrabio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intrabio Ltd filed Critical Intrabio Ltd
Priority to GBGB1613828.1A priority Critical patent/GB201613828D0/en
Publication of GB201613828D0 publication Critical patent/GB201613828D0/en
Priority to MDE20190593T priority patent/MD3482754T2/en
Priority to BR112019002719-0A priority patent/BR112019002719A2/en
Priority to EP20215877.0A priority patent/EP3865126A1/en
Priority to RU2019106493A priority patent/RU2749515C2/en
Priority to AU2017308864A priority patent/AU2017308864B2/en
Priority to SI201730032T priority patent/SI3359146T1/en
Priority to MDE20181131T priority patent/MD3359146T2/en
Priority to MA055947A priority patent/MA55947A/en
Priority to DK18210763.1T priority patent/DK3482754T3/en
Priority to ES18210763T priority patent/ES2849566T3/en
Priority to KR1020227039341A priority patent/KR20220154849A/en
Priority to MA43876A priority patent/MA43876B1/en
Priority to RS20210064A priority patent/RS61442B1/en
Priority to LTEP18210763.1T priority patent/LT3482754T/en
Priority to US16/324,301 priority patent/US11400067B2/en
Priority to PL17767933T priority patent/PL3359146T3/en
Priority to JP2019507811A priority patent/JP7393943B2/en
Priority to PCT/IB2017/054928 priority patent/WO2018029657A1/en
Priority to EP18210763.1A priority patent/EP3482754B1/en
Priority to ES17767933T priority patent/ES2716133T3/en
Priority to TNP/2019/000032A priority patent/TN2019000032A1/en
Priority to CA3033557A priority patent/CA3033557A1/en
Priority to SG11201901048VA priority patent/SG11201901048VA/en
Priority to EP24154769.4A priority patent/EP4342461A2/en
Priority to SI201730613T priority patent/SI3482754T1/en
Priority to MEP-2019-60A priority patent/ME03340B/en
Priority to PT17767933T priority patent/PT3359146T/en
Priority to MA45615A priority patent/MA45615B1/en
Priority to MX2019001577A priority patent/MX2019001577A/en
Priority to HUE17767933A priority patent/HUE041914T2/en
Priority to PT182107631T priority patent/PT3482754T/en
Priority to DK17767933.9T priority patent/DK3359146T3/en
Priority to HUE18210763A priority patent/HUE052837T2/en
Priority to EP17767933.9A priority patent/EP3359146B1/en
Priority to CN201780062740.XA priority patent/CN109843275A/en
Priority to LTEP17767933.9T priority patent/LT3359146T/en
Priority to RU2021115932A priority patent/RU2021115932A/en
Priority to PL18210763T priority patent/PL3482754T3/en
Priority to KR1020197007024A priority patent/KR102412724B1/en
Priority to KR1020227009897A priority patent/KR102467953B1/en
Priority to RS20190334A priority patent/RS58478B1/en
Priority to HK18112571.2A priority patent/HK1253282B/en
Priority to IL264610A priority patent/IL264610A/en
Priority to MX2021008432A priority patent/MX2021008432A/en
Priority to HRP20190344TT priority patent/HRP20190344T1/en
Priority to CY20191100279T priority patent/CY1121345T1/en
Priority to CY20211100017T priority patent/CY1123844T1/en
Priority to HRP20210153TT priority patent/HRP20210153T1/en
Priority to JP2022001694A priority patent/JP2022050564A/en
Priority to US17/854,027 priority patent/US20220331278A1/en
Priority to AU2023202903A priority patent/AU2023202903A1/en
Ceased legal-status Critical Current

Links

GBGB1613828.1A 2016-08-11 2016-08-11 Therapeutic agents for lysosomal storage disorders Ceased GB201613828D0 (en)

Priority Applications (52)

Application Number Priority Date Filing Date Title
GBGB1613828.1A GB201613828D0 (en) 2016-08-11 2016-08-11 Therapeutic agents for lysosomal storage disorders
MDE20190593T MD3482754T2 (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
BR112019002719-0A BR112019002719A2 (en) 2016-08-11 2017-08-11 acetyl leucine, or a pharmaceutically acceptable salt thereof, for use in methods related to lysosomal deposition diseases
EP20215877.0A EP3865126A1 (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
RU2019106493A RU2749515C2 (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and applications against lysosomal storage diseases
AU2017308864A AU2017308864B2 (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
SI201730032T SI3359146T1 (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
MDE20181131T MD3359146T2 (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
MA055947A MA55947A (en) 2016-08-11 2017-08-11 PHARMACEUTICAL COMPOSITIONS AND USES DIRECTED TO LYSOSOMIAL STORAGE DISORDERS
DK18210763.1T DK3482754T3 (en) 2016-08-11 2017-08-11 PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS TARGETED FOR LYSOSOMAL STORAGE DISEASES
ES18210763T ES2849566T3 (en) 2016-08-11 2017-08-11 Pharmaceutical Compositions and Uses Aimed at Lysosomal Storage Disorders
KR1020227039341A KR20220154849A (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
MA43876A MA43876B1 (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and their uses against lysosomal storage diseases
RS20210064A RS61442B1 (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
LTEP18210763.1T LT3482754T (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
US16/324,301 US11400067B2 (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
PL17767933T PL3359146T3 (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
JP2019507811A JP7393943B2 (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses for lysosomal storage disorders
PCT/IB2017/054928 WO2018029657A1 (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
EP18210763.1A EP3482754B1 (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
ES17767933T ES2716133T3 (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
TNP/2019/000032A TN2019000032A1 (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
CA3033557A CA3033557A1 (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
SG11201901048VA SG11201901048VA (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
EP24154769.4A EP4342461A2 (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
SI201730613T SI3482754T1 (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
MEP-2019-60A ME03340B (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
PT17767933T PT3359146T (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
MA45615A MA45615B1 (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and their uses against lysosomal overload diseases
MX2019001577A MX2019001577A (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders.
HUE17767933A HUE041914T2 (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
PT182107631T PT3482754T (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
DK17767933.9T DK3359146T3 (en) 2016-08-11 2017-08-11 PHARMACEUTICAL COMPOSITIONS AND USES AGAINST LYSOSOMAL STORAGE DISEASES
HUE18210763A HUE052837T2 (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
EP17767933.9A EP3359146B1 (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
CN201780062740.XA CN109843275A (en) 2016-08-11 2017-08-11 Pharmaceutical composition and purposes for lysosomal storage disease
LTEP17767933.9T LT3359146T (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
RU2021115932A RU2021115932A (en) 2016-08-11 2017-08-11 PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS AGAINST LYSOSOMAL DISEASES OF ACCUMULATION
PL18210763T PL3482754T3 (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
KR1020197007024A KR102412724B1 (en) 2016-08-11 2017-08-11 Pharmaceutical Compositions and Uses Associated with Lysosomal Storage Diseases
KR1020227009897A KR102467953B1 (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
RS20190334A RS58478B1 (en) 2016-08-11 2017-08-11 Pharmaceutical compositions and uses directed to lysosomal storage disorders
HK18112571.2A HK1253282B (en) 2016-08-11 2018-10-02 Pharmaceutical compositions and uses directed to lysosomal storage disorders
IL264610A IL264610A (en) 2016-08-11 2019-02-03 Pharmaceutical compositions and uses directed to lysosomal storage disorders
MX2021008432A MX2021008432A (en) 2016-08-11 2019-02-07 Pharmaceutical compositions and uses directed to lysosomal storage disorders.
HRP20190344TT HRP20190344T1 (en) 2016-08-11 2019-02-21 Pharmaceutical compositions and uses directed to lysosomal storage disorders
CY20191100279T CY1121345T1 (en) 2016-08-11 2019-03-08 PHARMACEUTICAL COMPOSITIONS AND USES ADDRESSED TO LYSOSOMIC STORAGE DISORDERS
CY20211100017T CY1123844T1 (en) 2016-08-11 2021-01-12 PHARMACEUTICAL COMPOSITIONS AND USES ADDRESSING LYSOSOMIC STORAGE DISORDERS
HRP20210153TT HRP20210153T1 (en) 2016-08-11 2021-01-29 Pharmaceutical compositions and uses directed to lysosomal storage disorders
JP2022001694A JP2022050564A (en) 2016-08-11 2022-01-07 Pharmaceutical compositions and uses directed to lysosomal storage disorders
US17/854,027 US20220331278A1 (en) 2016-08-11 2022-06-30 Pharmaceutical compositions and uses directed to lysosomal storage disorders
AU2023202903A AU2023202903A1 (en) 2016-08-11 2023-05-10 Pharmaceutical compositions and uses directed to lysosomal storage disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1613828.1A GB201613828D0 (en) 2016-08-11 2016-08-11 Therapeutic agents for lysosomal storage disorders

Publications (1)

Publication Number Publication Date
GB201613828D0 true GB201613828D0 (en) 2016-09-28

Family

ID=56985904

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1613828.1A Ceased GB201613828D0 (en) 2016-08-11 2016-08-11 Therapeutic agents for lysosomal storage disorders

Country Status (2)

Country Link
GB (1) GB201613828D0 (en)
MA (1) MA45615B1 (en)

Also Published As

Publication number Publication date
MA45615B1 (en) 2021-03-31
MA45615A (en) 2019-05-15

Similar Documents

Publication Publication Date Title
HK1256383A1 (en) Therapeutic agents
GB201709456D0 (en) Therapeutic agents
IL250685A0 (en) Cytotoxicity-inducing therapeutic agent
GB201509893D0 (en) Therapeutic agents
GB201517263D0 (en) Therapeutic agents
GB201603104D0 (en) Therapeutic agents
GB201410816D0 (en) Therapeutic agents
GB201410817D0 (en) Therapeutic agents
GB201410815D0 (en) Therapeutic agents
HK1245639A1 (en) Therapeutic agent for fibrosis
GB201608797D0 (en) Therapeutic use
GB201509885D0 (en) Therapeutic agents
GB201509888D0 (en) Therapeutic agents
GB201513299D0 (en) Therapeutic agents
GB201700553D0 (en) Therapeutic agents
GB201600376D0 (en) Novel therapeutic agents
GB201521767D0 (en) Therapeutic agents
SG11201700059WA (en) Therapeutic agent for keratoconjunctive disorder
GB201409653D0 (en) Pyrrolobenzodiazepine therapeutic agents
GB201706854D0 (en) Therapeutic agents for lysosomal storage disorders
GB201613828D0 (en) Therapeutic agents for lysosomal storage disorders
GB201705762D0 (en) Therapeutic agents for lysosomal storage disorders
GB201702552D0 (en) Therapeutic agents for lysosomal storage disorders
GB201517264D0 (en) Therapeutic agents
GB201620948D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)